Iron oxides as MR imaging contrast agents
β Scribed by Anne K. Fahlvik; Jo Klaveness; David D. Stark
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 884 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
CONTRAST AGENT-ENHANCED abdominal magneiric resonance (MR) imaging is likely to improve detection and diagnosis of liver disease. Recent research ha,s shown MR imaging to be potentially useful for quantitation and localization of diffuse liver disease and for noninvasive assessment of hepatic functi
## Abstract The safety and magnetic resonance (MR) imaging potential of BMS 180549, a new superparamagnetic iron oxide contrast agent, were evaluated in a phase I, openβlabel, placeboβcontrolled study involving 41 healthy subjects. No clinically significant postdose changes in physical examination
## Abstract The purpose of this brief review is to reduce the confusion surrounding the nomenclature of MRI contrast agents. There are several different categories of contrast agents for potential use in human diagnosis and several alternative names for each contrast agent, an array of choices that